Skip to main content

Hereditary Thrombophilia Caused by Abnormality of the Anticoagulant Protein C Pathway: Prenatal Diagnosis of Compound Heterozygous Protein C Deficiency by Direct Detection of the Mutation Sites

  • Conference paper
Pulmonary Embolism
  • 115 Accesses

Summary

In the present study, we report the molecular characterization of a hereditary compound heterozygous protein C (PC) deficiency observed in a male infant with neonatal purpura fulminans, and its prenatal diagnosis done by direct detection of the mutation sites in the PC gene. DNA-sequence analysis of the patient’s and his mother’s PC gene disclosed the presence of a deletion of one of the four consecutive G nucleotides encoding Trp380(TGG)-G1y381(GGT) in exon IX, resulting in a frameshift mutation, and an abnormal sequence of the 81 amino acid residues following Val381; this mutation was the same as previously reported as PC-Nagoya. The patient’s and his father’s PC gene had a missense mutation (G to A) in exon III with a substitution of Lys for G1u26; this mutation was named PC-Mie. This mutation may be responsible for the reduced immunological PC levels detected in the patient and the father, as measured by a monoclonal antibody that recognizes the Gla-domain of PC in a Ca2+-dependent manner (3.8% and 57%, respectively). Abnormal PC/activated PC (APC) purified from the father’s plasma showed a decreased binding ability to phospholipids, thrombomodulin, and to endothelial cell PC receptor, suggesting that Gla26-dependent conformation is required for these bindings. The proband died at 3 years old. Thereafter, the parents insisted on having a healthy baby. The second pregnancy resulted in spontaneous abortion. During the third and fourth pregnancies, prenatal screening of PC abnormalities was performed. We detected the above-mentioned mutations using two methods; one was based on the development of new restriction enzyme sites using mutagenic primer and the other was the single nucleotide primer extension. In the third pregnancy, the fetus presented both paternal and maternal mutations and thus the pregnancy was terminated by artificial abortion. In the fourth pregnancy, the fetus was free from both mutations, the pregnancy continued, and the woman underwent a cesarean section. The plasma level of Gla-PC antigen in the cord of the female baby was within the normal range. Postnatal analysis of her PC gene disclosed identical results to those done in the prenatal period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Stenflo J (1976) A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem 251: 355–363

    PubMed  CAS  Google Scholar 

  2. Kisiel W (1979) Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest 64: 761–769

    Article  PubMed  CAS  Google Scholar 

  3. Esmon NL, Owen WG, Esmon CT (1982) Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257: 859–864

    PubMed  CAS  Google Scholar 

  4. Esmon CT (1987) The regulation of natural anticoagulant pathways. Science 235: 1348–1352

    Article  PubMed  CAS  Google Scholar 

  5. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743–4746

    PubMed  CAS  Google Scholar 

  6. de Foun N, Haverkate F, Bertina RM, Koopman J, van Wijngddrden A, van Hinsbergh V (1986) The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood 67: 1189–1192

    Google Scholar 

  7. Suzuki K, Stenflo J, Dahlback B, Teodorsson B (1983) Inactivation of human coagulation factor V by activated protein C. J Biol Chem 258: 1914–1920

    PubMed  CAS  Google Scholar 

  8. van Hinsbergh V, Bertina RM, van Wijngddrden A, van Tilburg N, Emeis JJ, Haverkate F (1985) Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cellconditioned medium. Blood 65: 444–451

    PubMed  Google Scholar 

  9. Bajzar L, Nesheim M, Morser J, Tracy PB (1998) Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombinactivable fibrinolysis inhibitor. J Biol Chem 273: 2792–2798

    Article  PubMed  CAS  Google Scholar 

  10. Plutzky J, Hoskins JA, Long GL, Crabtree GR (1986) Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 83: 546–550

    Article  PubMed  CAS  Google Scholar 

  11. Broekmans AW, Veltkamp JJ, Bertina RM (1983) Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 309: 340–344

    Google Scholar 

  12. Marlar RA, Mastovich S (1990) Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment. Blood Coagul Fibrinolysis 1: 319–330

    Article  PubMed  CAS  Google Scholar 

  13. Suzuki K, Matsuda Y, Kusumoto H, Nishioka J, Terada M, Yamashita T, Hashimoto S (1985) Monoclonal antibodies to human protein C: effects on the biological activity of activated protein C and the thrombin-catalyzed activation of protein Cl. J Biochem (Tokyo) 97: 127–138

    CAS  Google Scholar 

  14. Suzuki K, Hayashi T, Koyama M, Yoshimura T, Shimamoto M, Kimura N, Kita M (1989) Rapid homogeneous enzyme immunoassay of plasma protein C. Clin Chim Acta 184: 227–233

    Article  PubMed  CAS  Google Scholar 

  15. Wakabayashi K, Sakata Y, Aoki N (1986) Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 261:11 097–11 105

    Google Scholar 

  16. Martinoli JL, Stocker K (1986) Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 43: 253–264

    Article  PubMed  CAS  Google Scholar 

  17. Ido M, Ohiwa M, Hayashi T, Nishioka J, Hatada T, Watanabe Y, Wada H, Shirakawa S, Suzuki K (1993) A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 70: 636–641

    PubMed  CAS  Google Scholar 

  18. Nishioka J, Ido M, Hayashi T, Suzuki K (1996) The G1a26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Thromb Haemost 75: 275–282

    PubMed  CAS  Google Scholar 

  19. Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S (1989) A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 264: 4872–4876

    PubMed  CAS  Google Scholar 

  20. Suzuki K, Nishioka J, Hashimoto S (1983) Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 258: 163–168

    Google Scholar 

  21. Fukudome K, Esmon CT (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269: 2648626491

    Google Scholar 

  22. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491

    Article  PubMed  CAS  Google Scholar 

  23. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467

    Article  PubMed  CAS  Google Scholar 

  24. Kuppuswamy MN, Hoffmann JW, Kasper CK, Spitzer SG, Groce SL, Bajaj SP (1991) Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci USA 88: 1143–1147

    Article  PubMed  CAS  Google Scholar 

  25. Yamamoto K, Tanimoto M, Emi N, Matsushita T, Takamatsu J, Saito H (1992) Impaired secretion of the elongated mutant of protein C (protein C-Nagoya). Molecular and cellular basis for hereditary protein C deficiency. J Clin Invest 90: 2439–2446

    Google Scholar 

  26. Tokunaga F, Wakabayashi S, Sato H, Arakawa M, Tawaraya H, Koide T (1992) Identification of one base deletion in exon IX of the protein C gene that causes a type I deficiency. Thromb Res 68: 417–423

    Article  PubMed  CAS  Google Scholar 

  27. Bovill EG, Tomczak JA, Grant B, Bhushan F, Pillemer E, Rainville IR, Long GL (1992) Protein CVermont: symptomatic type II protein C deficiency associated with two GLA domain mutations. Blood 79: 1456–1465

    PubMed  CAS  Google Scholar 

  28. Mimuro J, Muramatsu S, Kaneko M, Yoshitake S, Iijima K, Nakamura K, Sakata Y, Matsuda M (1993) An abnormal protein C (protein C Yonago) with an amino acid substitution of Gly for Arg-15 caused by a single base mutation of C to G in codon 57 (CGG - GGG). Deteriorated calcium-dependent conformation of the gammacarboxyglutamic acid domain relevant to a thrombotic tendency. Int J Hematol 57: 9–14

    Google Scholar 

  29. Zhang L, Jhingan A, Castellino FJ (1992) Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 80: 942–952

    PubMed  CAS  Google Scholar 

  30. Ido M, Hayashi T, Nishioka J, Itoh M, Minoura H, Toyoda N, Hirayama M, Kawasaki H, Sakurai M, Suzuki K (1996) Prenatal diagnosis of compound heterozygous deficiency of protein C by direct detection of the mutation sites. Thromb Haemost 76: 277–278

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Japan

About this paper

Cite this paper

Ido, M., Hayashi, T., Nishioka, J., Suzuki, K. (1999). Hereditary Thrombophilia Caused by Abnormality of the Anticoagulant Protein C Pathway: Prenatal Diagnosis of Compound Heterozygous Protein C Deficiency by Direct Detection of the Mutation Sites. In: Nakano, T., Goldhaber, S.Z. (eds) Pulmonary Embolism. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66893-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-66893-0_2

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-66895-4

  • Online ISBN: 978-4-431-66893-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics